Model fusion, the next phase in developing animal models for Parkinson's disease.
Within the past 25 years, discoveries of environmental and monogenetic forms of parkinsonism have shaped the direction of Parkinson's disease (PD) research and development of experimental systems to study PD. In this review, we outline a remarkable array of in vivo models available, with particular emphasis on their benefits and pitfalls and the contribution each has made to enhance our understanding of pathological mechanisms involved in PD. Further, we discuss the increasingly popular approach of "model fusion" to create a new generation of animal systems in which to study gene-environment interactions, and the usefulness of such models in capturing the most common events underlying PD.
Manning-Bog
Amy B
AB
The Parkinson's Institute, 1170 Morse Ave., Sunnyvale, CA 94089, USA.
Langston
J William
JW
D000818:Animals; D030801:Animals, Genetically Modified; D004195:Disease Models, Animal; D004777:Environment; D005796:Genes / Q000502:physiology; D006801:Humans; D009498:Neurotoxins / Q000633:toxicity; D010300:Parkinson Disease / Q000209:etiology / Q000235:genetics / Q000503:physiopathology
D009498:Neurotoxins